Arkolith/Insider Trading/MURA/Form 4

Cutler Adam D.

Chief Financial OfficerMural Oncology plc (MURA) · full profile →Form 4 · filed Nov 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$25K
Net Open-Market Flow
-$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 31, 2024Sell(S)7K$3.41$25K71K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-119800) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML